Generated by DeepSeek V3.2| Derrick Rossi | |
|---|---|
| Name | Derrick Rossi |
| Birth date | 1966 |
| Birth place | Toronto, Ontario, Canada |
| Nationality | Canadian |
| Fields | Stem cell biology, Immunology, Biotechnology |
| Workplaces | Harvard University, Stanford University, Boston Children's Hospital, Moderna |
| Alma mater | University of Toronto, University of Helsinki |
| Known for | Induced pluripotent stem cell research, co-founding Moderna |
| Awards | Newcomb Cleveland Prize, TIME 100 |
Derrick Rossi. He is a Canadian stem cell biologist and entrepreneur renowned for his pivotal research in cellular reprogramming and as a co-founder of the biotechnology company Moderna. His work on modified messenger RNA (mRNA) technology provided a foundational platform for the rapid development of COVID-19 vaccines. Rossi's career has spanned academia at institutions like Harvard Medical School and Stanford University, and the biotech industry, earning him significant recognition including a place on the TIME 100 list.
Born in Toronto, he pursued his undergraduate studies at the University of Toronto, earning a Bachelor of Science degree. He then completed his PhD in the Immunology program at the University of Helsinki in Finland, focusing on molecular biology techniques. His postdoctoral training was conducted at Stanford University under the mentorship of prominent stem cell researcher Irving Weissman, where he deepened his expertise in hematopoietic stem cell biology. This academic foundation in both immunology and stem cell science positioned him for his future groundbreaking contributions.
Rossi began his independent career as an assistant professor at Harvard Medical School and a principal faculty member at the Harvard Stem Cell Institute, with a laboratory at Boston Children's Hospital. His most influential scientific contribution came in 2010, when his team published a method in the journal Cell Stem Cell to create induced pluripotent stem cells using synthetic modified messenger RNA. This technique, a safer alternative to the viral vector methods pioneered by Shinya Yamanaka, avoided the risk of insertional mutagenesis and had high efficiency. Recognizing the broader therapeutic potential of this mRNA delivery platform, he co-founded the company Moderna in 2010 with colleagues from the Harvard community and Flagship Pioneering. He later co-founded other life sciences companies, including Magenta Therapeutics and Convelo Therapeutics, focusing on stem cell transplantation and neuroscience respectively.
For his 2010 paper on mRNA reprogramming, Rossi and his co-authors were awarded the Newcomb Cleveland Prize from the American Association for the Advancement of Science. His role in advancing biotechnology was recognized with his inclusion in the TIME 100 list of most influential people in 2021. He has also received the Merit Award from the International Society for Stem Cell Research and the Translational Research Award from the Harvard Stem Cell Institute. His election as a member to the American Institute for Medical and Biological Engineering further underscores his impact on the field.
Rossi maintains a relatively private personal life. He is married and has children. An advocate for science communication and entrepreneurship, he has participated in numerous panels and discussions at forums like the World Economic Forum. He continues to be involved in the biotechnology sector as an advisor and investor, supporting the next generation of scientific innovation in the Boston ecosystem and beyond.
Derrick Rossi's legacy is profoundly tied to the mRNA vaccine revolution. His laboratory's research directly enabled the core technology platform at Moderna, which was critical for the swift development and deployment of vaccines against SARS-CoV-2 during the COVID-19 pandemic. This contribution has had a monumental global impact on public health. Furthermore, his work on cellular reprogramming continues to influence regenerative medicine research, offering new pathways for disease modeling and potential cell therapies. Through his dual roles as a pioneering academic scientist and a successful entrepreneur, Rossi exemplifies the translation of fundamental biomedical research into transformative real-world applications. Category:Canadian biologists Category:Stem cell biologists Category:Harvard Medical School faculty Category:Moderna people Category:University of Toronto alumni Category:University of Helsinki alumni Category:1966 births Category:Living people